Cellvera

Cellvera is a biopharmaceutical company focused on discovering, developing, and commercializing oral therapies and monitoring tools to address unmet medical needs of patients with life-threatening viral diseases. With deep expertise in antiviral drug development, nucleotide chemistry, biology, biochemistry, and virology, Cellvera has established a nucleotide prodrug platform to develop new therapeutic candidates targeting single-stranded RNA (ssRNA) viruses, which are common causes of severe viral diseases, including Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, Dengue virus, Hepatitis C Virus (HCV), and Respiratory Syncytial Virus (RSV).